Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection

Trial Profile

Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2014

At a glance

  • Drugs Azithromycin/loteprednol-etabonate (Primary) ; Azithromycin; Loteprednol etabonate
  • Indications Bacterial infections; Blepharitis; Conjunctivitis; Keratitis; Ophthalmic infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Adapt Produtos Oftalmologicos
  • Most Recent Events

    • 10 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
    • 10 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top